Form 4: Aethlon Medical Director Edward Broenniman Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Director Edward Broenniman disposed of 1,645 shares of Aethlon Medical Inc. to cover tax obligations related to the vesting of restricted stock units.
Summary
- On June 28, 2024, Edward Broenniman, a director of Aethlon Medical Inc., disposed of 1,645 shares of common stock.
- The transaction was executed to cover tax withholding obligations upon the vesting of restricted stock units (RSUs) dated April 16, 2024.
- The shares were disposed of at a price of $0.499 per share.
- Following the transaction, Broenniman beneficially owns 43,819 shares of Aethlon Medical Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine disposal of shares to cover tax obligations, which is a common practice.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This provides transparency to the market regarding the actions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/16/2024 | Date of the restricted stock units (RSU) grant. |
| 06/28/2024 | Date of the transaction (disposal of shares). |
| 07/01/2024 | Date of signature on the Form 4 filing. |
Keywords
Aethlon Medical Inc, Edward Broenniman, Form 4, Share Disposal, Director, Tax Withholding, RSU Vesting, AEMD
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.